COVID-19 Clinical Trial Pipeline Study 2020: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights

DUBLIN, April 16, 2020 /PRNewswire/ -- The "Global COVID-19 Clinical Trial Pipeline Highlights, 2020" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Global COVID-19 Clinical Trial Pipeline Highlights, 2020 provides the most up-to-date information on key pipeline products in the global COVID-19 market. It covers emerging therapies for COVID-19 in active clinical development stages including early and late-stage clinical trials.

The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages: The report provides COVID-19 pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes: The report provides COVID-19 pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company: The report provides COVID-19 pipeline products by the company.

Short-term Launch Highlights: Find out which COVID-19 pipeline products will be launched in the US and Ex-US till 2025.

Key Topics Covered
1. COVID-19 Pipeline by Stages
2. COVID-19 Phase 3 Clinical Trial Insights
3. COVID-19 Phase 2 Clinical Trial Insights
4. COVID-19 Phase 1 Clinical Trial Insights
5. COVID-19 Preclinical Research Insights
6. COVID-19 Discovery Stage Insights
7. Appendix

List of Tables
Table 1: COVID-19 Phase 3 Clinical Trials, 2020
Table 2: COVID-19 Phase 2 Clinical Trials, 2020
Table 3: COVID-19 Phase 1 Clinical Trials, 2020
Table 4: COVID-19 Preclinical Research, 2020
Table 5: COVID-19 Discovery Stage, 2020

List of Figures
Figure 1: COVID-19 Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: COVID-19 Phase 3 Clinical Trial Highlights, 2020
Figure 3: COVID-19 Phase 2 Clinical Trial Highlights, 2020
Figure 4: COVID-19 Phase 1 Clinical Trial Highlights, 2020
Figure 5: COVID-19 Preclinical Research Highlights, 2020
Figure 6: COVID-19 Discovery Stage Highlights, 2020

For more information about this report visit https://www.researchandmarkets.com/r/54mgx9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/covid-19-clinical-trial-pipeline-study-2020-clinical-trial-stages-drug-mechanism-classes-companies-short-term-launch-highlights-301042189.html

SOURCE Research and Markets